Prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer. 2019

Stéphane Renaud, and Joseph Seitlinger, and David St-Pierre, and Richard Garfinkle, and Yaseen Al Lawati, and Francesco Guerrera, and Enrico Ruffini, and Pierre-Emmanuel Falcoz, and Gilbert Massard, and Lorenzo Ferri, and Jonathan Spicer
Department of Thoracic Surgery, Nancy University Hospital, Nancy, France.

OBJECTIVE Neutrophil to lymphocyte ratio (NLR) has been shown to be a promising biomarker in several cancers. Prognostic biomarkers are still needed to define good candidates for lung metastasectomy for colorectal cancer. We aimed to evaluate the role of NLR. METHODS Data from 574 patients who underwent lung metastasectomy for colorectal cancer in 3 departments of thoracic surgery from 2004 to 2014 were retrospectively reviewed. Overall survival (OS) and the time to pulmonary recurrence (TTPR) were the main end points. RESULTS Correlations between NLR and OS (R2 = 0.53), and NLR and TTPR (R2 = 0.389) were significant (P < 0.0001 for both), with corresponding Pearson R of -0.728 (P < 0.0001) and -0.624 (P < 0.0001), respectively. A receiver operating characteristic curve analysis highlighted an NLR cut-off value of 4.05 as the best predictor of OS and TTPR. NLR ≤4.05 was observed in 238 patients (41.4%). In the univariable analysis, the median OS was 117 months for patients with NLR ≤4.05 and decreased to 40 months for patients with NLR >4.05 (P < 0.0001). The median TTPR reached 52 months in case of NLR ≤4.05 and decreased to 12 months in patients with NLR >4.05. In the multivariable analysis, NLR ≤4.05 remained an independent favourable prognostic factor on both OS [hazard ratio [HR] 0.29, 95% confidence interval (CI) 0.167-0.503; P < 0.0001] and TTPR (HR 0.346, 95% CI 0.221-0.54; P < 0.0001). Significant correlations between NLR >4.05 and KRAS (Cramer's V = 0.241, P < 0.0001) and BRAF (Cramer's V = 0.153, P = 0.003) mutations were observed. CONCLUSIONS NLR is a simple and powerful predictor of outcomes in patients undergoing pulmonary metastasectomy for colorectal cancer.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Stéphane Renaud, and Joseph Seitlinger, and David St-Pierre, and Richard Garfinkle, and Yaseen Al Lawati, and Francesco Guerrera, and Enrico Ruffini, and Pierre-Emmanuel Falcoz, and Gilbert Massard, and Lorenzo Ferri, and Jonathan Spicer
November 2016, World journal of surgery,
Stéphane Renaud, and Joseph Seitlinger, and David St-Pierre, and Richard Garfinkle, and Yaseen Al Lawati, and Francesco Guerrera, and Enrico Ruffini, and Pierre-Emmanuel Falcoz, and Gilbert Massard, and Lorenzo Ferri, and Jonathan Spicer
March 2015, Annals of translational medicine,
Stéphane Renaud, and Joseph Seitlinger, and David St-Pierre, and Richard Garfinkle, and Yaseen Al Lawati, and Francesco Guerrera, and Enrico Ruffini, and Pierre-Emmanuel Falcoz, and Gilbert Massard, and Lorenzo Ferri, and Jonathan Spicer
May 2017, Asian Pacific journal of cancer prevention : APJCP,
Stéphane Renaud, and Joseph Seitlinger, and David St-Pierre, and Richard Garfinkle, and Yaseen Al Lawati, and Francesco Guerrera, and Enrico Ruffini, and Pierre-Emmanuel Falcoz, and Gilbert Massard, and Lorenzo Ferri, and Jonathan Spicer
March 2017, Journal of surgical oncology,
Stéphane Renaud, and Joseph Seitlinger, and David St-Pierre, and Richard Garfinkle, and Yaseen Al Lawati, and Francesco Guerrera, and Enrico Ruffini, and Pierre-Emmanuel Falcoz, and Gilbert Massard, and Lorenzo Ferri, and Jonathan Spicer
January 2015, FEBS open bio,
Stéphane Renaud, and Joseph Seitlinger, and David St-Pierre, and Richard Garfinkle, and Yaseen Al Lawati, and Francesco Guerrera, and Enrico Ruffini, and Pierre-Emmanuel Falcoz, and Gilbert Massard, and Lorenzo Ferri, and Jonathan Spicer
March 2018, Medicine,
Stéphane Renaud, and Joseph Seitlinger, and David St-Pierre, and Richard Garfinkle, and Yaseen Al Lawati, and Francesco Guerrera, and Enrico Ruffini, and Pierre-Emmanuel Falcoz, and Gilbert Massard, and Lorenzo Ferri, and Jonathan Spicer
July 2015, Clinics (Sao Paulo, Brazil),
Stéphane Renaud, and Joseph Seitlinger, and David St-Pierre, and Richard Garfinkle, and Yaseen Al Lawati, and Francesco Guerrera, and Enrico Ruffini, and Pierre-Emmanuel Falcoz, and Gilbert Massard, and Lorenzo Ferri, and Jonathan Spicer
January 2024, Revista espanola de enfermedades digestivas,
Stéphane Renaud, and Joseph Seitlinger, and David St-Pierre, and Richard Garfinkle, and Yaseen Al Lawati, and Francesco Guerrera, and Enrico Ruffini, and Pierre-Emmanuel Falcoz, and Gilbert Massard, and Lorenzo Ferri, and Jonathan Spicer
January 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology,
Stéphane Renaud, and Joseph Seitlinger, and David St-Pierre, and Richard Garfinkle, and Yaseen Al Lawati, and Francesco Guerrera, and Enrico Ruffini, and Pierre-Emmanuel Falcoz, and Gilbert Massard, and Lorenzo Ferri, and Jonathan Spicer
January 2021, Technology in cancer research & treatment,
Copied contents to your clipboard!